|
R. Lewis Dark: Arguing in Favor of Regional Laboratory Networks
Two stories in this issue of The Dark Report demonstrate why regional laboratory networks are a business model which should be revisited by hospital laboratories with outreach programs.
Seattle provides a great example of how an existing laboratory network gives hospitals in that region an additional business option. PACLAB, an eight-hospital laboratory network, has steadily grown in size, professionalism, and market impact. When two hospitals went shopping for a commercial laboratory partner, PACLAB was able to provide a credible proposal in both cases. (See pages 10-14.)
Plans in Florida to select a single laboratory to do all testing statewide for Medicare beneficiaries is a direct threat to independent laboratories and hospital lab outreach programs. Laboratories in that state are scrambling to develop a lobbying coalition that can stop this proposal. A regional laboratory network would help in this effort. (See pages 5-7.)
What is ironic about the situation in Florida is that the state's major hospital laboratory outreach programs actually did have a network. The Florida Reference Laboratory Network (FRLN) was developed to help these lab outreach programs bid and service large managed care contracts in the state. However, when closed-panel HMO contracts became less of an issue, the lab network's organizers allowed it to languish in recent years.
In contrast, Detroit's regional laboratory network is probably"best in class." Over a ten-year period beginning in 1992, Joint Venture Hospital Laboratories (JVHL) successfully captured almost every significant managed care contract in Michigan. As many as 150 Michigan hospital laboratories participate in certain contracts. Like PACLAB, JVHL is a work in progress. Each year additional resources are developed and put in service to the benefit of member hospital laboratories and their physician-clients.
Current developments in Seattle and the State of Florida remind us that hospital lab outreach programs can accomplish more by collaborating than by working alone. If payers continue to develop contracting models which cover larger regions, then lab outreach programs should respond by creating a regional laboratory resource. By the way, anatomic pathologists would benefit from the same kind of regional collaboration. But that's another opinion for another column!
MT Contracts HIV & HCV
In Hospital Lab Scandal
Maryland state health officials
uncover numerous serious violations
CEO SUMMARY: An extraordinary story is unfolding in Baltimore hospital laboratory. Maryland state health officials have uncovered serious operational deficiencies, particularly with HIV and HCV testing performed over a 14-month period. During this same time, a medical technologist now infected with both HIV and HCV claims a malfunctioning laboratory instrument was the source of her infection.
Florida Issues State RFP
For Sole Medicaid Lab
Effort to award $100 million contract
using a 28-day RFP process is criticized
CEO SUMMARY: If competitive bidding for Medicare business is something universally viewed as bad by the laboratory industry, then the lab services RFP issued by Florida's Medicaid program must be considered a serious threat to the status quo. Further, the fact that Medicaid officials in Florida designed a 28-day RFP process to award a single lab with an exclusive, 3-year, $100 million contract earned criticism from both labs and employers.
LabCorp Buys MDS Labs
In New York and Georgia
MDS concedes U.S. lab market
and its lab automation strategy
CEO SUMMARY: It's the final chapter of the"Canadian Invasion" of the U.S. laboratory testing market. In the mid-1990s, both MDS and Dynacare built a sizeable presence in the United States as they both worked to develop joint ventures with hospital laboratories. Dynacare was acquired by LabCorp in 2002. In selling two U.S. lab operations, MDS has taken the first steps to reposition its business in this country.
Seattle Hospital Lab JVs
Involve Quest & LabCorp
One victory and one loss provide insight
into blood brothers' hospital lab strategies
CEO SUMMARY: Joint ventures and collaborative business relationships between hospital laboratories and commercial laboratories continue to be a difficult business model. Recent events in Seattle demonstrate the challenges and frustrations of establishing such ventures, then making them successful. One footnote to the Seattle story is the success of a regional laboratory network at grabbing market share.
Pathology & Oncology Update: Welsh Carson Pays $1.14 Billion
To Acquire U.S. Oncology, Inc.
It's another billion-dollar Wall Street bet
on the future prospects in oncology services
Dark Index: AmeriPath Reports on 2003,
Its First Year as a Private Firm
Company reports that Quest is internalizing
anatomic pathology contracts at a steady rate
INTELLIGENCE:
Employers Develop"Doctor ScoreCards"
As Quality Measure
ADD To: Scorecards
|